| Ticker |
TNDM
|
| CIK | 0001438133 |
| SIC | 3841 |
| Sector | Manufacturing |
| Industry Category | Medical Equipment |
| Industry Group | Surgical, Medical, And Dental Instruments And Supplies |
| Address | 12400 HIGH BLUFF DRIVE, San Diego, CA, 92130 |
| Website | tandemdiabetes.com |
| Phone | 858-366-6900 |
| CEO | John F. Sheridan |
| Employees | 2,600 |
Our team will help you customize a package that meets the needs of your business.
Request a Consultation|
Standardized FinancialsdocsIntrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals. For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards. Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics: |
|||||||||||||||||||||
|
Income Statement
|
Balance Sheet
|
||||||||||||||||||||
|
Cash Flow Statement
|
Calculations
|
||||||||||||||||||||
|
Latest NewsdocsIntrinio provides up-to-date news articles on every US company from various sources. Here are several examples: |
Tandem Diabetes Care Announces Upcoming Conference ParticipationSAN DIEGO, July 31, 2025--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will host meetings and present a company update at the following investor conferences: 1 of Wall Street’s Favorite Stock to Research Further and 2 Facing HeadwindsWall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts. Tandem Diabetes Care, Inc. (TNDM) Expected to Beat Earnings Estimates: Should You Buy?Tandem Diabetes Care (TNDM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Is There An Opportunity With Tandem Diabetes Care, Inc.'s (NASDAQ:TNDM) 39% Undervaluation?Key Insights Tandem Diabetes Care's estimated fair value is US$27.68 based on 2 Stage Free Cash Flow to Equity Tandem... Why Tandem Diabetes (TNDM) Stock Is Trading Up TodayShares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 5.4% in the morning session after the stock appeared to rebound from a recent 52-week low as investors looked ahead to its upcoming quarterly earnings report. The upward movement followed the stock hitting a 52-week low just ten days prior, a level that may have attracted investors looking for a potential bargain. Market participants were also likely positioning themselves ahead of Tandem's second-quarter 2025 financ |
